WORLD-GOVERNMENT-SUMMIT
11.3.2021 11:02:12 CET | Business Wire | Press release
The World Government Summit Dialogues saw world leaders outline solutions to humanity’s most urgent challenges during the virtual event on 9-10 March.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210311005126/en/
Dr. David Nabarro, Special Envoy on COVID-19 to the World Health Organization (WHO), claimed the unfair weighting of vaccine access in favour of rich countries will delay the global recovery from the healthcare and economic crises, potentially beyond 2022.
“While the COVAX effort is commendable, if a few countries take the majority of the supplies and leave minimal cash and vaccine supplies behind for the rest, this is not ethical,” Dr. Nabarro said.
The current “free-for-all” approach to vaccine supplies with “a small number of nations trying to outbid one another”, doesn’t work. But “fair access to vaccine for everybody, the objective for immunization, at least by 2022, is a reasonable prospect,” he said.
Earlier, Dr. Tedros Ghebreyesus, Director-General, WHO, said: “Vaccine nationalism will only prolong the pandemic, and the human and economic suffering that goes with it. Health must be seen not as a cost to be contained but as an investment in productive and resilient populations, and a key to sustainable development.”
Later, the Right Honourable Lord Martin Rees, President, the Royal Society, said reasons to study and explore other planets must be carefully considered. He claimed: “The idea of Elon Musk to have a million people settle on Mars is a dangerous delusion. Living on Mars is no better than living on the South Pole or the tip of Mount Everest.
“The only reason for humans to go to space would be for adventure. To live on Mars is not going to be easy. Mars has a hostile environment.”
His thoughts were backed-up by the eminent astrophysicist, Dr. Neil deGrasse Tyson, who said: “To ship a billion people to another planet to help them survive a catastrophe on earth seems unrealistic.”
The World Government Summit Dialogues convened leaders from around the world virtually to predict the trends that will shape the future, post-pandemic society. For more details about the event, visit: https://www.worldgovernmentsummit.org/
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20210311005126/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
The LYCRA Company Appoints Hua Du as Chief Executive Officer15.9.2026 14:00:00 CEST | Press release
The LYCRA Company, a global leader in developing fiber and technology solutions for the apparel and personal care industries, announced today that Hua Du has been appointed chief executive officer, effective September 14, as the company enters its next chapter following the successful completion of its financial restructuring. Du succeeds Dean Williams, who served as interim chief executive officer and will continue in his role as chief financial officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260915565505/en/ The LYCRA Company Appoints Hua Du as Chief Executive Officer. With 30 years of leadership experience in the specialty chemical and biotechnology industries, Du is well positioned to lead the company into its next chapter. Du brings 30 years of leadership experience in the specialty chemical and biotech-based industries, driving transformational growth across global businesses. Du most recently served as CEO of
Visa, Circle and Haun Ventures Back Velocity in Series A Extension, Bringing Total Series A Funding to $48 million15.9.2026 14:00:00 CEST | Press release
Velocity, the stablecoin payments and treasury platform, today announced a $10 million extension to its Series A, with investment from Visa Ventures, Circle Ventures, Ripple, Haun Ventures, Translink Capital and Mirana Ventures. The extension follows Velocity’s $38 million Series A announced last month and will support the company’s work to bring stablecoin infrastructure to issuers, acquirers, payment providers, financial institutions and merchants worldwide. “We are excited to welcome several new investors to Velocity, including Visa through Visa Ventures,” said Eric Queathem, founder and CEO of Velocity. “From day one, we have focused on improving how money moves through the payments ecosystem. These investors operate at the center of that ecosystem and will provide invaluable insight as we use stablecoins to transform the experience.” Velocity is building infrastructure that enables institutions and businesses to use stablecoins for settlement, liquidity and treasury operations wit
Riskified Brings Identity Risk Intelligence to Zendesk, Helping Retailers Stop Returns Fraud Without Sacrificing Customer Experience15.9.2026 14:00:00 CEST | Press release
Riskified Identity Risk Intelligence equips Zendesk Industry Agents with insights drawn from billions of orders, claims, and chargebacks, helping retailers identify abuse and resolve legitimate claims with confidence Riskified (NYSE: RSKD), a global leader in ecommerce fraud detection and risk intelligence, today announced a new partnership with Zendesk that brings its Identity Risk Intelligence directly into Zendesk’s customer service workflow. The integration gives human and AI support agents real-time signals, helping retailers resolve legitimate claims faster while curbing returns and refund abuse that drains revenue. According to the National Retail Federation, U.S. retailers saw $849.9 billion in returns in 2025, approximately 9% of which were fraudulent. Based on those figures, Riskified calculates that return fraud costs U.S. retailers approximately $76.5 billion, and the losses are far higher when accounting for global returns fraud. Shoppers admit it too: one in four acknowle
Ori Biotech Announces 10-year, $120M Partnership to Advance Automated Manufacturing for Commercial Cell Therapies15.9.2026 14:00:00 CEST | Press release
Collaboration to switch a commercial cell therapy onto the IRO® platform for an undisclosed pharma partner Oribiotech Ltd. (Ori), a leader in advanced cell and gene therapy (CGT) manufacturing technology, today announced a strategic collaboration with an undisclosed biopharmaceutical company to integrate the IRO® platform into a commercial cell therapy manufacturing process in a deal valued at up to $120M in services, milestones, equipment and consumable purchases over the next 10 years. The collaboration is designed to modernize the partner’s autologous cell therapy manufacturing infrastructure with the aim of expanding patient access to current and future potentially transformative cell therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260915757436/en/ The IRO platform Autologous cell therapies, manufactured from a patient's own cells, require precise, reliable and scalable manufacturing processes. Meeting that req
Vertex Partners With World Champion Skier Lindsey Vonn to Raise Awareness of JOURNAVX®, a Non-Opioid Medicine Approved for the Treatment of Moderate-to-Severe Acute Pain15.9.2026 13:30:00 CEST | Press release
- Vonn shares her experience using JOURNAVX to manage her acute pain after a career-altering injury at the 2026 Winter Games - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company has partnered with world champion skier Lindsey Vonn to raise awareness of JOURNAVX® (suzetrigine), a prescription non-opioid medicine for the treatment of moderate-to-severe acute pain in adults. Approved by the U.S. Food and Drug Administration (FDA) in January 2025, JOURNAVX marked the first new class of pain medicine in over 20 years — since then JOURNAVX has been prescribed to over one million Americans. During the 2026 Winter Games in Milano Cortina, Lindsey suffered a serious crash during her downhill race. The fall resulted in multiple injuries that required immediate surgery and several additional procedures. Now, Lindsey is sharing her story and her personal experience treating her moderate-to-severe acute pain with JOURNAVX. “I have experienced countless injuries thro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom